MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
$5,015K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net income (loss)
    • Deferred income taxes
    • Prepaid expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Accounts receivable, net
    • Accounts payable and accrued exp...
    • Accrued research and development...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Loss on disposal of property and equipment
NaN 3 -7 -85
Net income (loss)
40,773 -2,276 40,080 -13,787
Depreciation and amortization
443 460 475 946
Share-based compensation expense
3,653 3,823 3,612 9,815
Non-cash interest expense
419 418 418 832
Non-cash lease expense
444 435 426 827
Deferred income taxes
19,196 -1,746 27,772 14,775
Accounts receivable, net
59,097 -73,623 34,193 4,282
Prepaid expenses and other current assets
-5,997 -1,086 248 471
Other assets
-121 -100 -63 -284
Accounts payable and accrued expenses
-4,886 -318 10,693 -4,174
Accrued research and development costs
-1,102 -274 -1,168 -2,664
Operating lease liabilities
-621 -612 -603 -1,156
Other liabilities
-219 -141 249 3,856
Net cash provided by operating activities
5,121 74,575 47,583 4,886
Purchases of property and equipment
NaN -1 2 33
Net cash used in investing activities
NaN 1 -2 -33
Proceeds from exercise of stock options and employee stock purchase plan
NaN 122 0 94
Net cash provided by (used in) financing activities
NaN 122 0 94
Effect of exchange rate changes on cash and cash equivalents
-106 351 -26 -654
Net increase in cash and cash equivalents
5,015 75,049 47,555 4,293
Cash and cash equivalents, beginning of period
215,456 140,407 88,559 NaN
Cash and cash equivalents, end of period
220,471 215,456 140,407 NaN
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income (loss)$40,773K Deferred income taxes$19,196K Prepaid expenses andother current assets-$5,997K Share-based compensationexpense$3,653K Non-cash lease expense$444K Depreciation andamortization$443K Non-cash interestexpense$419K Other assets-$121K Net cash provided byoperating activities$5,121K Canceled cashflow$65,925K Net increase in cashand cash...$5,015K Canceled cashflow$106K Accounts receivable, net$59,097K Accounts payable andaccrued expenses-$4,886K Accrued research anddevelopment costs-$1,102K Operating leaseliabilities-$621K Other liabilities-$219K Effect of exchange ratechanges on cash and cash...-$106K

IRONWOOD PHARMACEUTICALS INC (IRWD)

IRONWOOD PHARMACEUTICALS INC (IRWD)